Ergoferon

DRUG8 trials

Conditions

Acute Respiratory Viral InfectionsAcute Upper Respiratory Tract InfectionsImmunization Against COVID-19InfluenzaViral Intestinal InfectionViral Respiratory Infection

Phase 3

Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults

CompletedNCT01765920

Materia Medica HoldingAcute Upper Respiratory Tract Infections

Start: 2012-12-31End: 2015-04-30Updated: 2021-01-05

Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

CompletedNCT01843842

Materia Medica HoldingAcute Upper Respiratory Tract Infections

Start: 2013-04-30End: 2015-03-31Updated: 2018-11-29

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

CompletedNCT05069649

Materia Medica HoldingImmunization Against COVID-19

Start: 2021-10-06End: 2022-04-14Updated: 2024-12-05

Phase 4

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

CompletedNCT01804946

Materia Medica HoldingInfluenza

Start: 2011-02-28End: 2014-10-31Updated: 2015-06-23

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

CompletedNCT01850446

Materia Medica HoldingInfluenza

Start: 2015-02-20End: 2018-04-16Updated: 2020-04-16

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

CompletedNCT03039699

Materia Medica HoldingViral Intestinal Infection

Start: 2016-06-23End: 2019-06-01Updated: 2020-10-19

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

CompletedNCT03039621

Materia Medica HoldingAcute Respiratory Viral Infections

Start: 2016-10-07End: 2019-01-09Updated: 2021-08-27

Unknown Phase

Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

CompletedNCT04413929

Materia Medica HoldingViral Respiratory Infection

Start: 2016-10-31End: 2017-04-30Updated: 2021-04-02

Related Papers

Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial

Terapevticheskii arkhiv2022-12-261 citations

Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.